Five Warning Signs Your Sample Distribution Program Is at Risk
Pharmaceutical sample distribution remains one of the most heavily regulated and closely scrutinized activities within life sciences. While samples continue to play an important role in enabling healthcare providers to evaluate therapies and support patient access, the operational complexity required to manage a compliant program has increased significantly
Impiricus Launches QPharma® Integration to Power Real-Time Compliant HCP Sampling
QPharma is excited to announce our integration with Impiricus, bringing the next level of real-time HCP engagement and compliant sampling in a single action.
Rethinking Sample Distribution: Why Growth Opportunities May Lie Beyond the Highest Deciles
For decades, pharmaceutical sampling strategies have largely followed a familiar formula: allocate more samples to the highest-prescribing healthcare providers and fewer to those with lower prescribing volumes. The logic is straightforward. High-decile providers see more patients, write more prescriptions, and therefore have historically been viewed as the most efficient targets for sample distribution.
The Pharmaceutical Sales Representative Has Changed. Has Leadership Kept Up?
For many pharmaceutical leaders, field sales is familiar territory. They built their careers calling on physicians, earning access one office at a time, delivering product messages, and growing prescriptions through consistent face-to-face engagement. It was a model that worked remarkably well for decades
What the First Year of Commercialization Often Reveals
Launching a pharmaceutical product represents a significant milestone, often marking the culmination of years of research, development, regulatory review, and strategic planning.
Pharmaceutical Commercial Operations… Validated, Controlled, and Audit-Ready: What It Takes to Manage Software Changes in a Regulated Environment
Pharmaceutical samples have long been a recognized part of the healthcare landscape: providing patients with immediate access to therapy and giving clinicians exposure to new treatments. But across hospital systems, policies on samples vary widely. Some organizations continue to allow them under defined conditions, while others have eliminated them entirely.
Breaking the Silence: Why Organizations Operate in Silos, and What It Means for Vendors
Pharmaceutical samples have long been a recognized part of the healthcare landscape: providing patients with immediate access to therapy and giving clinicians exposure to new treatments. But across hospital systems, policies on samples vary widely. Some organizations continue to allow them under defined conditions, while others have eliminated them entirely.
Why Do Some Hospitals Reject Pharmaceutical Samples?
Pharmaceutical samples have long been a recognized part of the healthcare landscape: providing patients with immediate access to therapy and giving clinicians exposure to new treatments. But across hospital systems, policies on samples vary widely. Some organizations continue to allow them under defined conditions, while others have eliminated them entirely.
Turning HCP Engagement into Real-Time Sample Fulfillment
Download The Background A mid-sized biopharma company identified a critical gap in its digital HCP engagement strategy. While text-based campaigns successfully drove engagement, they exposed a key limitation: Healthcare professionals frequently expressed immediate interest in product samples. No compliant way to fulfill requests in real time Follow-up required manual, delayed workflows. QPharma’s Solution Real-time, […]
From Sales-Led to Orchestrated Omnichannel Engagement: Turning Strategy into Execution
As pharmaceutical commercial organizations continue to evolve, omnichannel engagement has moved from aspiration to expectation. Most companies have defined their strategies, invested in digital capabilities, and expanded their use of data. Yet a gap remains between what omnichannel promises and what it consistently delivers.
